Literature DB >> 2091929

Results of psychological testing of patients aged 3-6 years.

U Michel1, E Schmidt, U Batzler.   

Abstract

Cognitive development of early treated PKU children (132) was investigated by intelligence tests, tests for visual perception, motor and language development. Deviations from test norms occurred at 5 years of age concerning performance IQ, mathematical thinking, and visual perception. With the exception of mathematical thinking, "normal" results were obtained at the age of 6 years. Correlation with levels of plasma Phe revealed a relation between quality of dietary control and performance IQ. Results are discussed in light of methodological aspects and with respect to treatment consequence.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2091929     DOI： 10.1007/BF02126297

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  11 in total

1.  Study design and description of patients.

Authors:  P Lutz; H Schmidt; U Batzler
Journal:  Eur J Pediatr       Date:  1990       Impact factor: 3.183

2.  The effects of diet discontinuation in children with phenylketonuria.

Authors:  R Koch; C G Azen; N Hurst; E G Friedman; K Fishler
Journal:  Eur J Pediatr       Date:  1987       Impact factor: 3.183

3.  Six-year follow up of phenylalanine intakes and plasma phenylalanine concentrations.

Authors:  U Wendel; K Ullrich; H Schmidt; U Batzler
Journal:  Eur J Pediatr       Date:  1990       Impact factor: 3.183

4.  Paired comparisons between early treated PKU children and their matched sibling controls on intelligence and school achievement test results at eight years of age.

Authors:  R Koch; C Azen; E G Friedman; M L Williamson
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

5.  Psychoeducational findings among children treated for phenylketonuria.

Authors:  K Fishler; C G Azen; R Henderson; E G Friedman; R Koch
Journal:  Am J Ment Defic       Date:  1987-07

6.  Psychiatric diagnosis and behavioral characteristics of phenylketonuric children.

Authors:  G M Realmuto; B D Garfinkel; M Tuchman; M Y Tsai; P N Chang; R O Fisch; S Shapiro
Journal:  J Nerv Ment Dis       Date:  1986-09       Impact factor: 2.254

7.  Effect of age at loss of dietary control on intellectual performance and behavior of children with phenylketonuria.

Authors:  N A Holtzman; R A Kronmal; W van Doorninck; C Azen; R Koch
Journal:  N Engl J Med       Date:  1986-03-06       Impact factor: 91.245

8.  Behavioural deviance in children with early treated phenylketonuria.

Authors:  J E Stevenson; J Hawcroft; M Lobascher; I Smith; O H Wolff; P J Graham
Journal:  Arch Dis Child       Date:  1979-01       Impact factor: 3.791

9.  Phenylalanine control and family functioning in early-treated phenylketonuria.

Authors:  M Reber; A E Kazak; P Himmelberg
Journal:  J Dev Behav Pediatr       Date:  1987-12       Impact factor: 2.225

10.  Predictors of intelligence quotient and intelligence quotient change in persons treated for phenylketonuria early in life.

Authors:  S E Waisbren; B E Mahon; R R Schnell; H L Levy
Journal:  Pediatrics       Date:  1987-03       Impact factor: 7.124
View more
  5 in total

1.  Study design and description of patients.

Authors:  P Lutz; H Schmidt; U Batzler
Journal:  Eur J Pediatr       Date:  1990       Impact factor: 3.183

2.  Preliminary neuropsychological test results.

Authors:  L M de Sonneville; E Schmidt; U Michel; U Batzler
Journal:  Eur J Pediatr       Date:  1990       Impact factor: 3.183

3.  Significance of the in vivo deuterated phenylalanine load for long-term phenylalanine tolerance and psycho-intellectual outcome in patients with PKU.

Authors:  F K Trefz; U Batzler; T König; U Michel; E Schmidt; H Schmidt; H Bickel
Journal:  Eur J Pediatr       Date:  1990       Impact factor: 3.183

4.  Effects of concurrent phenylalanine levels on sustained attention and calculation speed in patients treated early for phenylketonuria.

Authors:  E Schmidt; P Burgard; A Rupp
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

5.  Intellectual performance of children with maple syrup urine disease.

Authors:  C Hilliges; D Awiszus; U Wendel
Journal:  Eur J Pediatr       Date:  1993-02       Impact factor: 3.183
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.